Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,249
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
for
Non-Muscle Invasive Bladder Cancer
Location: Nashville TN, Knoxville TN, Germantown TN, St Louis MO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06319820
Phase3, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Nashville TN, Birmingham AL, Indianapolis IN,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase3, Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Nashville TN, Greenwood IN, Gahanna OH, Chicago IL,
Sponsor: Theralase® Technologies Inc.
Sex: All
Age: 18+
Code: NCT03945162
Phase2, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Nashville TN, Jeffersonville IN, Atlanta GA,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
for
Prostate Cancer,
Location: Nashville TN, Jeffersonville IN, Durham NC,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT04729114
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Nashville TN, Atlanta GA, Germantown TN, Cincinnati OH,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Homewood AL, Memphis TN, St Louis MO,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Location: Nashville TN, Fort Wayne IN, Pinehurst NC
Sponsor: Locate Bio Pty Ltd
Sex: All
Age: 22 - 70+
Code: NCT06462729
Phase1, Phase2, Recruiting
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
for
Degenerative Disc Disease, Spine Fusion, Back Pain
Location: Nashville TN, St Louis MO, Grand Rapids MI,
Sponsor: Kuros Biosurgery AG
Sex: All
Age: 18+
Code: NCT04679844
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Smyrna TN, Bowling Green KY, Decatur GA,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase1, Phase2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Nashville TN, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase1, Phase2, Recruiting
The Ailliance Post-Market Clinical Study
for
Spinal Deformity, Spinal Degenerative Disorder,
Location: Nashville TN, Louisville KY, Bloomington IN,
Sponsor: Medtronic Spinal and Biologics
Sex: All
Age: 18+
Code: NCT05856370
Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control